Atossa Therapeutics ( ($ATOS) ) has issued an update. On January 6, 2026, Atossa Therapeutics announced that the U.S. Food and Drug Administration ...

Avenga, a global digital engineering and AI-driven software transformation specialist, today announced that Clay Van Doren ...

Contract expansion reflects nearly four-year relationship supporting large-scale cloud security and compliance operationsASHBURN, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS) ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet medical needs, today announced that the U.S. Food and Drug Administration ...

Comparing Coloplast to ConvaTec, the latter has been seeing double-digit growth in China, where Coloplast has been struggling ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet ...

The global high-performance computing market witnessed robust growth in recent years, reaching USD 37.1 billion in 2020, with projections to hit USD 54.4 billion by 2027, at a CAGR of 5.6% during 2021 ...

Atossa Therapeutics (ATOS) announced that the U.S. FDA issued a “Study May Proceed” letter for the company’s study in metastatic breast cancer ...

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, ...

India's information technology firms are expected to report another muted quarter, as tepid demand in the U.S. and ...

Regulators said they would look at whether the deal for Manus, a Singapore start-up with Chinese roots, complied with China’s ...

Europe’s drone-filled vision for the future of war Last spring, 3,000 British soldiers deployed an invisible automated ...